[144] Varex Imaging Corp SEC Filing

Rhea-AI Filing Summary

Varex Imaging Corp (VREX) filed a Form 144 reporting a proposed sale of 3,174 common shares held by a person whose restricted stock vested on 05/15/2025. The shares are to be sold through Fidelity Brokerage Services LLC on or about 09/19/2025 on the NASDAQ, with an aggregate market value reported as $39,167.16. The filer indicates the shares were acquired as compensation upon vesting and reports no other sales in the past three months. The filing includes the standard Rule 144 representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small restricted‑stock sale; immaterial to company valuation.

The filing documents a routine liquidity event following restricted stock vesting: 3,174 shares worth $39,167.16 to be sold via Fidelity. Compared with the 41.5 million shares outstanding reported in the form, this represents an immaterial issuance and proposed sale (approximately 0.0076% of outstanding shares). There is no indication of prior sales in the last three months and no disclosed material nonpublic information. For investors, this is a routine insider liquidity notice rather than a signal of company performance.

Corporate Governance Expert

TL;DR: Compliance filing shows standard post‑vesting sale; no governance red flags.

The document shows the seller is following Rule 144 disclosure requirements and notes the shares were acquired via restricted stock vesting and paid as compensation. The use of a broker and a specified approximate sale date aligns with customary procedures. The form includes the required seller representation about material information but lacks any signature or identification details in the provided content. Based solely on this filing content, there are no governance concerns or unusual disclosure issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3174	39167.16	41500000	09/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2025	Restricted Stock Vesting	Issuer			3174	05/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does VREX's Form 144 report?

The Form 144 reports a proposed sale of 3,174 common shares acquired by restricted stock vesting on 05/15/2025, to be sold via Fidelity on or about 09/19/2025.

How much are the shares worth in the filing?

The aggregate market value reported for the 3,174 shares is $39,167.16.

What was the nature of acquisition for the shares?

The shares were acquired as compensation upon restricted stock vesting from the issuer on 05/15/2025.

Is this sale material relative to Varex Imaging's outstanding shares?

No. The filing lists 41,500,000 shares outstanding, so 3,174 shares represent an immaterial fraction of total shares.

Does the filing indicate any undisclosed material information?

The filer provides the Rule 144 representation that they do not know any material adverse information about the issuer that has not been publicly disclosed.